NCT07657403

Brief Summary

This study is designed for patients with brain tumors located in eloquent brain areas involved in language, motor, or major functional brain networks. The purpose of the study is to determine whether connectome-guided navigation-assisted microsurgical resection can better preserve neurological function after surgery than conventional tractography-guided surgery. Participants who meet the study criteria will be assigned to one of two surgical planning strategies. In the experimental group, patients will undergo preoperative diffusion tensor imaging and resting-state functional MRI for individualized brain network reconstruction, and these data will be integrated with intraoperative navigation and neurophysiological monitoring to guide the resection boundary. In the control group, surgery will be guided by conventional DTI tractography-assisted navigation. The main outcome is the rate of postoperative functional preservation. Other outcomes include extent of tumor resection, postoperative complications, time to neurological recovery, overall survival, and quality of life. Patients will be evaluated before surgery and followed after surgery with clinical examinations, neurological assessments, and MRI at prespecified time points.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
30mo left

Started Nov 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Nov 2025Dec 2028

Study Start

First participant enrolled

November 1, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 14, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 18, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

June 18, 2026

Status Verified

November 1, 2025

Enrollment Period

2.2 years

First QC Date

June 14, 2026

Last Update Submit

June 14, 2026

Conditions

Keywords

Connectome-guided surgeryEloquent area brain tumorBrain network navigationDiffusion tensor imagingDTI tractographyResting-state fMRIFunctional preservationMicrosurgical resectionIntraoperative neurophysiological monitoring

Outcome Measures

Primary Outcomes (1)

  • Postoperative Functional Preservation Rate

    The proportion of participants with preservation of neurological function at 6 months after surgery compared with baseline, based on neurological examination and protocol-specified functional assessments.

    6 months after surgery

Secondary Outcomes (2)

  • Extent of Resection

    Within 24 to 72 hours after surgery

  • Incidence of Postoperative Complications

    Within 30 days after surgery

Study Arms (2)

Connectome-Guided Surgery Group

EXPERIMENTAL

Participants in this arm will undergo connectome-guided navigation-assisted microsurgical resection. The surgical strategy includes preoperative diffusion tensor imaging and resting-state functional MRI-based brain network reconstruction, integrated with intraoperative neuronavigation and neurophysiological monitoring to guide resection boundaries and optimize postoperative functional preservation.

Procedure: Connectome-Guided Navigation-Assisted Microsurgical Resection

Conventional Tractography-Guided Surgery Group

ACTIVE COMPARATOR

Participants in this arm will undergo conventional DTI tractography-guided microsurgical resection using standard surgical planning and navigation procedures. This group serves as the comparator for evaluating postoperative functional preservation and extent of resection.

Procedure: Conventional DTI Tractography-Guided Tumor Resection

Interventions

Microsurgical resection of eloquent-area brain tumors guided by preoperative diffusion tensor imaging and resting-state functional MRI-based brain network reconstruction. The intervention integrates connectome-informed surgical planning, intraoperative neuronavigation, and neurophysiological monitoring to define individualized resection boundaries with the goal of maximizing tumor removal while preserving neurological function.

Also known as: Brain network-guided surgery, Connectome-guided surgery, DTI and rs-fMRI-guided tumor resection
Connectome-Guided Surgery Group

Microsurgical resection of eloquent-area brain tumors guided by conventional diffusion tensor imaging tractography-assisted navigation according to standard surgical planning procedures. This intervention serves as the comparator for evaluation of postoperative functional preservation, extent of resection, and other clinical outcomes.

Also known as: Conventional tractography-guided surgery, DTI-guided microsurgical resection, Standard tractography-assisted tumor resection
Conventional Tractography-Guided Surgery Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients clinically diagnosed with brain tumors involving language areas, motor areas, or major functional brain networks, including the default mode network, central executive network, dorsal attention network, or ventral attention network.
  • Karnofsky Performance Status (KPS) score of 70 or higher.
  • Preoperative MRI demonstrating a spatial relationship between the tumor and major white matter tracts, such as the corticospinal tract or arcuate fasciculus.
  • No other neurological disease or underlying condition that may cause neurological dysfunction.
  • No prior treatment for a brain tumor in the same region, such as radiotherapy.
  • Tumor not extensively adherent to multiple critical network nodes.
  • Planned craniotomy for tumor resection and provision of written informed consent by the patient or legally authorized representative.

You may not qualify if:

  • Pathologically or clinically suspected non-neoplastic brain lesion.
  • Multifocal tumors.
  • Incomplete evaluation data.
  • Withdrawal from the study by the patient or legally authorized representative for any reason.
  • Pregnancy, lactation, possibility of pregnancy, or planned pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, 100021, China

RECRUITING

MeSH Terms

Conditions

Brain Neoplasms

Interventions

Diffusion Tensor Imaging

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

NeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiffusion Magnetic Resonance ImagingMagnetic Resonance ImagingTomographyDiagnostic Techniques, NeurologicalInvestigative Techniques

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study. Blinding of participants and treating surgeons is not feasible because of the nature of the surgical interventions.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized in a 1:1 ratio to one of two parallel groups. The experimental group will undergo connectome-guided navigation-assisted microsurgical resection based on preoperative DTI and resting-state fMRI brain network reconstruction combined with intraoperative navigation and neurophysiological monitoring. The control group will undergo conventional DTI tractography-guided tumor resection.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2026

First Posted

June 18, 2026

Study Start

November 1, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

June 18, 2026

Record last verified: 2025-11

Locations